MOLECULAR CONTROL OF CALCIUM INFLUX AT THE ER-PLASMA MEMBRANE JUNCTIONS
ER-血浆膜连接处钙流入的分子控制
基本信息
- 批准号:10386835
- 负责人:
- 金额:$ 29.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAnimal ModelBiochemicalBiological ProcessBiophysicsCalciumCalcium ChannelCalcium SignalingCardiovascular DiseasesCell membraneCellsCellular Metabolic ProcessClinicalClinical MedicineCommunicationComplexCouplingDataDevelopmentDiseaseDrug TargetingEF Hand MotifsExposure toFunctional disorderGene ExpressionGenerationsGeneticGoalsHomeostasisHumanImmunologic Deficiency SyndromesKineticsKnock-outKnockout MiceKnowledgeLabelLaboratoriesLinkLocationLymphocyteLymphocyte ActivationMammalsMapsMembraneMembrane FusionMissionModelingMolecularMuscleMuscle ContractionNeoplasm MetastasisPathologicPathway interactionsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesPhosphatidylinositolsPhysiologicalPhysiological ProcessesPilot ProjectsProtein EngineeringProtein FamilyProteinsProteomicsPublic HealthResearchRouteSTIM1 geneSevere Combined ImmunodeficiencyShapesSideSignal PathwaySignal TransductionSignaling MoleculeSignaling ProteinSiteStimulusStructure-Activity RelationshipSystemT-Cell ActivationTechniquesTestingTherapeuticTherapeutic InterventionTransgenic MiceTranslatingTubular Aggregate MyopathiesUnited States National Institutes of Healthbaseclinically relevantdisabilitydruggable targetextracellulargain of function mutationhuman diseaseinnovationinsightmouse modelnoveloptogeneticsoverexpressionpublic health relevancetherapeutic targettherapeutically effectivetooltrafficking
项目摘要
Project Summary / Abstract.
Store-operated calcium entry (SOCE) constitutes a major calcium entry pathway in mammals to control
lymphocyte activation, muscle contraction, gene expression and cell metabolism. The calcium release-
activated calcium (CRAC) channel composed of ORAI-STIM represents a prototypical example of SOCE in
lymphocytes. The clinical relevance of SOCE is exemplified by two human diseases, the severe combined
immunodeficiency (SCID) and tubular aggregate myopathy (TAM), which are caused by loss- or gain-of-function
mutations in ORAI1 and STIM1, respectively. Augmented SOCE is also implicated in cardiovascular disorders
and cancer metastasis. Therefore, CRAC channel has been pursued as an attractive drug target for therapeutic
intervention. Tremendous efforts have been directed to establish ORAI-STIM as the minimal two-component
system to couple ER calcium store depletion with calcium influx across the plasma membrane. The regulatory
machinery dedicated to the ORAI-STIM signaling, nonetheless, still remains incompletely defined.
In this proposal, the PI aims to bridge this critical knowledge gap by unveiling the functions of two novel
SOCE modulators, which reside at distinct subcellular locations to act on different steps of ORAI-STIM
signaling: the initial activation of STIM within the ER lumen and the later stabilization of ORAI-STIM complexes
at ER-PM membrane contact sites (MCS), where the close appositions of two membranes are separated by a
gap distance of 10-30 nm. In Aim 1, based on preliminary findings from proteomic profiling of potential STIM1
interactors within the ER lumen, the PI will define how a previously-unrecognized multiple EF-hand protein
cooperates with the luminal domain of STIM1 (EFSAM) to shape the activation and deactivation kinetics of
SOCE. The PI will employ a new “ER-to-PM” trafficking strategy to expose the luminal domain toward the
extracellular side, thereby overcoming a major impediment to studies on the liminal sides of ER-resident
signaling proteins. In Aim 2, capitalizing on the discovery of a TMEM family protein as a regulator of calcium
influx at ER-PM MCS, the PI will define how this modulator responds to physiological stimuli to remodel the
assembly of ER-PM junctions and PIP homeostasis to sustain SOCE. The generation of innovative optogenetic
tools and a transgenic mouse model to dissect calcium signaling and protein-PIP interactions will further
accelerate our structure-function relationship studies on these novel regulators.
Overall, the new mechanistic insights gained through the proposed study will lead to advances in the
constantly-revitalized field of calcium signaling, and in parallel, spawn the vibrant field of membrane contact
sites. In the long run, discoveries made in the study can be translated into the development of effective
therapeutics targeting aberrant calcium and phosphoinositide signaling.
项目摘要/摘要。
钙库操纵的钙进入(SOCE)是哺乳动物控制钙进入的主要途径
淋巴细胞激活、肌肉收缩、基因表达和细胞代谢。
由 ORAI-STIM 组成的活化钙 (CRAC) 通道代表了 SOCE 的典型例子
SOCE 的临床相关性以两种人类疾病为例,即严重的联合疾病。
免疫缺陷(SCID)和管状聚集性肌病(TAM),由功能丧失或获得引起
ORAI1 和 STIM1 的突变也与心血管疾病有关。
因此,CRAC通道已被视为有吸引力的治疗药物靶点。
为了将 ORAI-STIM 建立为最小的两部分,我们付出了巨大的努力。
将内质网钙储备耗尽与钙跨质膜流入耦合的系统。
然而,专用于 ORAI-STIM 信号传导的机制仍然不完全定义。
在这项提案中,PI 旨在通过揭示两本小说的功能来弥合这一关键知识差距
SOCE 调节剂,位于不同的亚细胞位置,作用于 ORAI-STIM 的不同步骤
信号传导:ER 腔内 STIM 的初始激活和 ORAI-STIM 复合物的后期稳定
在 ER-PM 膜接触位点 (MCS),其中两个膜的紧密并置被一个
间隙距离为 10-30 nm 在目标 1 中,基于潜在 STIM1 蛋白质组学分析的初步发现。
ER 腔内的相互作用因子,PI 将定义以前未被识别的多重 EF 手蛋白
与 STIM1 (EFSAM) 的管腔结构域配合,塑造 STIM1 的激活和失活动力学
SOCE 将采用新的“ER-to-PM”贩运策略,将 luminal 域暴露给
细胞外侧,从而克服了 ER 驻留阈侧研究的主要障碍
在目标 2 中,利用 TMEM 家族蛋白作为钙调节剂的发现。
当 ER-PM MCS 流入时,PI 将定义该调节器如何响应生理刺激以重塑
ER-PM 连接和 PIP 稳态的组装以维持 SOCE 创新光遗传学的产生。
剖析钙信号传导和蛋白质-PIP 相互作用的工具和转基因小鼠模型将进一步
加速我们对这些新型调节剂的结构与功能关系的研究。
总体而言,通过拟议的研究获得的新的机制见解将导致在
钙信号传导场不断焕发活力,同时产生充满活力的膜接触场
从长远来看,研究中的发现可以转化为有效性的发展。
针对异常钙和磷酸肌醇信号传导的治疗方法。
项目成果
期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An Engineered Split-TET2 Enzyme for Chemical-inducible DNA Hydroxymethylation and Epigenetic Remodeling.
一种用于化学诱导 DNA 羟甲基化和表观遗传重塑的工程化 Split-TET2 酶。
- DOI:10.3791/56858
- 发表时间:2017-12-18
- 期刊:
- 影响因子:0
- 作者:Minjung Lee;Yubin Zhou;Yun Huang
- 通讯作者:Yun Huang
Optogenetic engineering to probe the molecular choreography of STIM1-mediated cell signaling.
光遗传学工程探索 STIM1 介导的细胞信号传导的分子编排。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:16.6
- 作者:Ma, Guolin;He, Lian;Liu, Shuzhong;Xie, Jiansheng;Huang, Zixian;Jing, Ji;Lee, Yi;Wang, Rui;Luo, Hesheng;Han, Weidong;Huang, Yun;Zhou, Yubin
- 通讯作者:Zhou, Yubin
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors.
表征热休克蛋白 (HSP) 在癌症标志中的双重功能效应,以帮助开发 HSP 抑制剂。
- DOI:
- 发表时间:2020-11-23
- 期刊:
- 影响因子:12.3
- 作者:Zhang, Zhao;Jing, Ji;Ye, Youqiong;Chen, Zhiao;Jing, Ying;Li, Shengli;Hong, Wei;Ruan, Hang;Liu, Yaoming;Hu, Qingsong;Wang, Jun;Li, Wenbo;Lin, Chunru;Diao, Lixia;Zhou, Yubin;Han, Leng
- 通讯作者:Han, Leng
Novel intramolecular photoinduced electron transfer-based probe for the Human Ether-a-go-go-Related Gene (hERG) potassium channel.
用于人类 Ether-a-go-go 相关基因 (hERG) 钾通道的新型分子内光诱导电子转移探针。
- DOI:
- 发表时间:2015-12-21
- 期刊:
- 影响因子:0
- 作者:Liu Z;Zhou Y;Du L;Li M
- 通讯作者:Li M
Inside-out Ca(2+) signalling prompted by STIM1 conformational switch.
由 STIM1 构象转换引发的由内而外的 Ca(2 ) 信号传导。
- DOI:
- 发表时间:2015-07-17
- 期刊:
- 影响因子:16.6
- 作者:Ma, Guolin;Wei, Ming;He, Lian;Liu, Chongxu;Wu, Bo;Zhang, Shenyuan L;Jing, Ji;Liang, Xiaowen;Senes, Alessandro;Tan, Peng;Li, Siwei;Sun, Aomin;Bi, Yunchen;Zhong, Ling;Si, Hongjiang;Shen, Yuequan;Li, Minyong;Lee, Mi;Zhou, Weibin;Wang
- 通讯作者:Wang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yubin Zhou其他文献
Yubin Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yubin Zhou', 18)}}的其他基金
Selective targeting of a Rho GTPase mutant for peripheral T cell lymphoma treatment
选择性靶向 Rho GTPase 突变体治疗外周 T 细胞淋巴瘤
- 批准号:
10721439 - 财政年份:2023
- 资助金额:
$ 29.18万 - 项目类别:
Optogenetic toolkit for precise control of organellar calcium signaling
用于精确控制细胞器钙信号传导的光遗传学工具包
- 批准号:
10706462 - 财政年份:2022
- 资助金额:
$ 29.18万 - 项目类别:
Engineering Smart Antibody-like Protein Scaffolds with precision switches
具有精密开关的工程智能类抗体蛋白支架
- 批准号:
10708167 - 财政年份:2022
- 资助金额:
$ 29.18万 - 项目类别:
Engineering Smart Antibody-like Protein Scaffolds with precision switches
具有精密开关的工程智能类抗体蛋白支架
- 批准号:
10538760 - 财政年份:2022
- 资助金额:
$ 29.18万 - 项目类别:
Molecular control of calcium influx at the ER-plasma membrane junctions
内质网-质膜连接处钙内流的分子控制
- 批准号:
8899617 - 财政年份:2014
- 资助金额:
$ 29.18万 - 项目类别:
Molecular control of calcium influx at the ER-plasma membrane junctions
内质网-质膜连接处钙内流的分子控制
- 批准号:
9257436 - 财政年份:2014
- 资助金额:
$ 29.18万 - 项目类别:
MOLECULAR CONTROL OF CALCIUM INFLUX AT THE ER-PLASMA MEMBRANE JUNCTIONS
ER-血浆膜连接处钙流入的分子控制
- 批准号:
9912777 - 财政年份:2014
- 资助金额:
$ 29.18万 - 项目类别:
Molecular control of calcium influx at the ER-plasma membrane junctions
内质网-质膜连接处钙内流的分子控制
- 批准号:
8765824 - 财政年份:2014
- 资助金额:
$ 29.18万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Non-invasive molecular imaging tool for rapid, longitudinal assessment of localized metabolic disruptions in animal research and care
非侵入性分子成像工具,用于快速纵向评估动物研究和护理中的局部代谢紊乱
- 批准号:
10602045 - 财政年份:2023
- 资助金额:
$ 29.18万 - 项目类别:
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
用于连续监测心力衰竭生物标志物的无试剂传感器技术
- 批准号:
10636089 - 财政年份:2023
- 资助金额:
$ 29.18万 - 项目类别:
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication
开发环肽 Nef 抑制剂以促进 HIV-1 根除
- 批准号:
10759561 - 财政年份:2023
- 资助金额:
$ 29.18万 - 项目类别:
Modeling Progressive Familial Intrahepatic Cholestasis Type I Caused by ATP8B1 deficiency
ATP8B1 缺乏引起的进行性家族性肝内胆汁淤积 I 型建模
- 批准号:
10722357 - 财政年份:2023
- 资助金额:
$ 29.18万 - 项目类别: